Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2010
05/26/2010CN101711778A Pachymaran composition used for suppressing tumours and preventing and treating metastasis and relapse and application
05/26/2010CN101711777A Method for removing pesticide residue in production process of lucid ganoderma extract
05/26/2010CN101711776A Method for manufacturing activated ganoderma lucidum spore powder
05/26/2010CN101711775A Fermentation composition for fermenting Agaricus blazei Murrill through probiotics
05/26/2010CN101711774A Application of Phellinus pini polysaccharide extract in preparing medicament for preventing and treating tumor metastasis
05/26/2010CN101711765A Dispersing tablet containing tegafur, gimeracil and oteracil potassium
05/26/2010CN101711764A Tegafur compound capsules floating in stomach for curing gastric cancer
05/26/2010CN101711760A Thiophene derivative with excellent function of blood glucose reduction and adduct PPAR alpha/gamma double agonists thereof
05/26/2010CN101711759A Application of cumarins compound in preparing medicine for inhibiting tumor growth
05/26/2010CN101711756A Application of 3-phenyl-3-(4-nitryl phenylamino)-1-(4-chlorphenyl)-1-acetone as non-steroidal androgen receptor regulating agent
05/26/2010CN101711740A Method for preparing targeted curcumin nanoparticles for treating ulcerative colitis
05/26/2010CN101711736A Method for preparing medicine-carrying microvesicle
05/26/2010CN101711735A Slow-release medicament release system as well as preparation method and application thereof
05/26/2010CN101314042B Water-soluble 4'-nor-epipodophyllotoxin derivant and preparation method thereof
05/26/2010CN101167930B Traditional Chinese medicinal preparation for treating digestive system cancer
05/26/2010CN101164551B Optimized formula for liver cancer-resisting traditional Chinese medicine active ingredient
05/26/2010CN101143895B Polypeptide with tumour targeting effects and preparation method thereof
05/26/2010CN101129748B Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same
05/26/2010CN101120977B Medicine for treating tumor
05/26/2010CN101100672B Modified HPV E6-E7 fusion gene and coding protein thereof
05/26/2010CN101066458B Application of cell nucleus targeting administration system capable of reversing tumor cell resistance
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101050170B New type natural active compound for anti tumor, preparation method, and application
05/26/2010CN101032504B Application of liquiritin in medicines
05/26/2010CN101003528B Diterpene compound and derivative in kaurene class of new dissymmetry, and its preparation method and uses
05/25/2010US7723523 Tetrahydropyridothiophenes
05/25/2010US7723510 MicroRNA molecules
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723478 DKR polypeptides
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
05/25/2010US7723339 signal transduction inhibitor is a PDGF receptor tyrosine kinase inhibitor or an active ingredient which decreases the activity of the epidermal growth factor; antiproliferative agent
05/25/2010US7723330 Heterobicyclic pyrazole compounds and methods of use
05/25/2010US7723312 heat shock protein 27 inhibitors; RNA interference; nuclease resistance
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010US7723293 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4.
05/25/2010US7723107 Pharmaceutical composition for inducing an immune response in a human or animal
05/25/2010US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7722866 using a monoclonal antibody or an antigen-binding portion which binds to an epitope of EphB4 polypeptide and inhibiting the growth of cancer as a result of such binding by causing cell death
05/25/2010CA2672513C Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
05/25/2010CA2646779A1 Bioscience ix
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2577589C Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation
05/25/2010CA2489136C Novel 3-(4-oxo-40-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
05/25/2010CA2464681C Preparation of thioarabinofuranosyl compounds and use thereof
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2375727C Cytofectin dimers and methods of use thereof
05/25/2010CA2368621C Methods and compositions for treating solid tumors
05/25/2010CA2361892C Treatment of tumors with genetically engineered herpes virus
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2330237C Broad specificity dna damage endonuclease
05/25/2010CA2322424C 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
05/25/2010CA2245890C Use of an extract of cimicifuga racemosa
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/25/2010CA2173130E Glutathione s-transferase-activated compounds
05/24/2010CA2698639A1 Azo and diaza derivatives and uses thereof in phototherapy
05/20/2010WO2010057203A2 Hdl particles for delivery of nucleic acids
05/20/2010WO2010057197A1 Cancer vaccine compositions and methods of using the same
05/20/2010WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
05/20/2010WO2010057048A1 Therapies for hematologic malignancies
05/20/2010WO2010057028A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056985A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056948A2 Humanized anti-il-6 antibodies
05/20/2010WO2010056919A2 Eflornithine prodrugs, conjugates and salts, and methods of use thereof
05/20/2010WO2010056620A1 Tetrasubstituted pyridazines hedgehog pathway antagonists
05/20/2010WO2010056575A1 P70 s6 kinase inhibitor and egfr inhibitor combination therapy
05/20/2010WO2010056574A1 P70 s6 kinase inhibitor and mtor inhibitor combination therapy
05/20/2010WO2010056563A1 Akt and p70 s6 kinase inhibitors
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010056378A2 Extracellular matrix compositions for the treatment of cancer
05/20/2010WO2010056320A2 Pi3k/mtor kinase inhibitors
05/20/2010WO2010056148A1 Mucosal vaccine for immunotherapy of diseases caused by human papillomaviruses
05/20/2010WO2010055950A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055900A1 Method for producing dendritic cells
05/20/2010WO2010055894A1 Organic arsenic-containing compound, and composition for inhibiting growth of tumor comprising the compound
05/20/2010WO2010055886A1 Agent for control of sensitivity to ultraviolet light
05/20/2010WO2010055473A1 Methods of treating tumor cells using rhcc protein, fragment or variant
05/20/2010WO2010055358A1 Suppression of cancer
05/20/2010WO2010055340A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
05/20/2010WO2010055148A2 Dosage of oligonucleotides suitable for the treatment of tumors
05/20/2010WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010WO2010055082A2 New crystal form of sunitinib malate
05/20/2010WO2010054764A1 Heteroaromatic compounds for use as hif inhibitors
05/20/2010WO2010054763A1 Heterocyclically substituted aryl compounds as hif inhibitors
05/20/2010WO2010054762A1 Aminoalkyl-substituted compounds as hif inhibitors
05/20/2010WO2010054606A2 Triterpenoid 2-deoxy glycosides, method of preparation thereof and use thereof as medicaments
05/20/2010WO2010054565A1 The water-soluble prodrug of (r)-(-)-bicalutamide, its preparation method and uses thereof
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 2211